From: Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men
Men | Neck circumference (cm) | P | |||
---|---|---|---|---|---|
≤33 | 33–34 | 34–36 | >36 | ||
N | 229 | 156 | 246 | 113 | |
Age (yr) | 52.55 ± 15.39 | 49.63 ± 15.50 | 49.39 ± 14.43 | 50.35 ± 14.14 | 0.11 |
weight (kg) | 59.39 ± 7.75 | 62.44 ± 8.08 | 65.67 ± 8.16 | 66.18 ± 9.89 | <0.01 |
Waist circumference (cm) | 74.81 ± 7.91 | 76.82 ± 7.32 | 79.28 ± 7.07 | 81.46 ± 8.00 | <0.01 |
Hip circumference (cm) | 88.72 ± 5.68 | 89.44 ± 5.10 | 91.72 ± 5.65 | 93.78 ± 6.22 | <0.01 |
Waist to hip ratio | 0.84 ± 0.08 | 0.85 ± 0.06 | 0.90 ± 0.05 | 0.87 ± 0.07 | 0.24 |
BMI (kg/m2) | 21.65 ± 2.52 | 22.16 ± 2.57 | 22.79 ± 2.50 | 23.43 ± 2.97 | <0.01 |
SBP (mmHg) | 124.05 ± 19.45 | 126.25 ± 19.17 | 127.47 ± 17.27 | 132.59 ± 17.01 | <0.01 |
DBP (mmHg) | 76.33 ± 12.67 | 76.32 ± 11.78 | 77.03 ± 12.09 | 78.06 ± 12.41 | 0.35 |
FBG (mmol/L) | 5.40 ± 1.00 | 5.31 ± 1.56 | 5.37 ± 1.21 | 5.70 ± 1.67 | 0.08 |
Fasting insulin (pmol/L) | 24.9(16.4–33.1) | 27.2(19.2–39.9) | 27.7(19.0–35.3) | 30.4(21.2–45.8) | <0.01 |
HbA1c (%) | 5.26 ± 0.67 | 5.25 ± 1.09 | 5.28 ± 0.86 | 5.47 ± 1.12 | 0.17 |
HOMA-IR | 0.86(0.57–1.09) | 0.88(0.56–1.39) | 0.90(0.66–1.22) | 1.05(0.72–1.61) | <0.01 |
Total cholerterol (mmol/L) | 4.78 ± 0.84 | 4.80 ± 0.93 | 4.72 ± 0.82 | 5.14 ± 1.24 | <0.01 |
LDL-cholesterol (mmol/L) | 2.73 ± 0.60 | 2.80 ± 0.67 | 2.80 ± 0.59 | 3.09 ± 0.79 | <0.01 |
HDL-cholesterol (mmol/L) | 1.43 ± 0.30 | 1.36 ± 0.27 | 1.31 ± 0.25 | 1.34 ± 0.27 | <0.01 |
Triglycerides (mmol/L) | 1.10(0.81–1.37) | 1.15(0.89–1.56) | 1.25(0.90–1.80) | 1.37(0.99–1.93) | <0.01 |
Creatinine (umol/L) | 85.63 ± 13.87 | 88.08 ± 13.74 | 89.96 ± 15.26 | 88.86 ± 15.80 | <0.01 |
eGFR (ml/min/1.732) | 93.11 ± 16.92 | 90.45 ± 16.56 | 89.03 ± 16.08 | 89.71 ± 16.57 | 0.04 |
ALT (U/L) | 19(14–25) | 21(15–29) | 19(15–26) | 19(15–29) | 0.18 |
AST (U/L) | 24(20–29) | 24(20–29) | 23(20–28) | 22(19–27) | 0.35 |
NAFLD, % | 10.04 % | 16.67 % | 26.02 % | 30.97 % | <0.01 |